Latest News
Revvity launches IVDR-certified solution for early detection of type 1 diabetes
24 September 2026 - Life sciences and diagnostics company Revvity Inc (NYSE:RVTY) on Thursday launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified multiplex autoantibody detection solution designed to support population-wide screening...
Viking Therapeutics plans offerings of common stock and convertible senior notes
24 September 2026 - Viking Therapeutics Inc (Nasdaq:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced on Wednesday its intention to offer, subject to marke...
FDA Advisory Committee votes in favour of GRAIL's Galleri multi-cancer early detection test
24 September 2026 - GRAIL Inc, a healthcare company focused on early cancer detection,, announced on Wednesday a favourable vote from the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee of the US Food and Drug ...
Astellas doses first patient in Phase 3 lung cancer study
24 September 2026 - Japanese pharmaceutical company Astellas Pharma Inc (TSE:4503) announced on Wednesday that the first patient has been dosed in a Phase 3 study evaluating setidegrasib, a novel, investigational KRAS G12D-targeted protein degrader, ...
AstraZeneca's Trixeo Aerosphere approved in EU for asthma maintenance treatment
23 September 2026 - Biopharmaceutical company AstraZeneca (LSE: AZN) (STO: AZN) (NYSE: AZN) declared on Wednesday that it has received European Commission approval for Trixeo Aerosphere as a maintenance treatment for asthma in patients aged 12 and ov...